AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimfirst-M 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimfirst-M 2 Tablet SR

Diabetic patients may find the dual-action medication, Glimfirst-M 2 SR, beneficial. This anti-diabetic formulation combines two active ingredients for managing type 2 diabetes in adults. It effectively regulates blood glucose, achieving optimal control. Always take Glimfirst-M 2 SR with meals, consistently at the same time daily for maximum efficacy. Your physician will determine the appropriate dosage, potentially adjusting it based on your blood sugar readings. Continuous use is crucial; discontinuing treatment without medical supervision can elevate blood glucose, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, trembling) and appropriate management. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be avoided due to its potential to lower blood sugar. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur in some individuals. Glimfirst-M 2 SR is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Patients with a history of heart problems should consult their physician prior to use. Pregnant or breastfeeding women should seek medical advice before commencing treatment. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, will be necessary as directed by your doctor.

Uses of Glimfirst-M 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimfirst-M 2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst-M 2 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Glimfirst-M 2 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimfirst-M 2 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst-M 2 Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Glimfirst-M 2 Tablet SR works:

Glimfirst-M 2 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances insulin secretion from the pancreas, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimfirst-M 2 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimfirst-M 2 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Sustained-release Glimfirst-M 2 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glimfirst-M 2 Tablet SR, as dose modification may be necessary. Severe kidney disease contraindicates the use of Glimfirst-M 2 Tablet SR. Physician consultation is recommended. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimfirst-M 2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced starting dose is typically recommended for those with mild to moderate liver disease; its use is contraindicated in severe cases.

What if you forget to take Glimfirst-M 2 Tablet SR :

Should you forget a dose of Glimfirst-M 2 Tablet SR, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimfirst-M 2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimfirst-M 2 Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimfirst-M 2 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimfirst-M 2 Tablet SR and seek immediate medical attention.
Glimfirst-M 2 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimfirst-M 2 Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimfirst-M 2 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glimfirst-M 2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimfirst-M 2 Tablet SR and alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimfirst-M 2 Tablet SR
98
MRP 120
18% off